CompaniesAvant Immunotherapeutics

Avant Immunotherapeutics

defunct
About

Defunct Company

Areas of Focus

Categories

MergedBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (3)
View all

Total Trials

3

As Lead Sponsor

2

As Collaborator

1

Total Enrollment

554

By Phase

PHASE2: 3

By Status

COMPLETED: 2TERMINATED: 1
Funding History (20)
8-K
Aug 19, 2025
8-K
Aug 7, 2025
8-K
Jun 6, 2025
8-K
May 8, 2025
DEF 14A
Apr 21, 2025
8-K
Feb 27, 2025
8-K
Nov 6, 2024
8-K
Aug 8, 2024
8-K
Jun 14, 2024
8-K
May 6, 2024
Related Companies
Celldex----------------------------------------if You Believe Any Of This Information Is Incorrect
merged